Abstract | OBJECTIVES: Renal transplant offers a definitive therapeutic modality for patients with end-stage renal disease; however, 50% to 70% of these patients have graft dysfunction after the transplant. Proactive prevention management of metabolic complications may reduce posttransplant morbidity and mortality in these patients. MATERIALS AND METHODS: A retrospective and prospective review of 120 kidney transplant recipients during 5 years' follow-up was performed to analyze the incidence and status of the various metabolic complications after a renal transplant. RESULTS: CONCLUSIONS:
|
Authors | Irfan A Shera, Qayser Yousuf, Mushtaq A Mir, Imtiyaz A Wani, M Saleem Najar |
Journal | Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
(Exp Clin Transplant)
Vol. 12
Issue 1
Pg. 25-30
(Feb 2014)
ISSN: 2146-8427 [Electronic] Turkey |
PMID | 24471720
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers
- Immunosuppressive Agents
|
Topics |
- Adult
- Allografts
- Biomarkers
(blood)
- Diabetes Mellitus
(blood, diagnosis, epidemiology)
- Dyslipidemias
(blood, diagnosis, epidemiology)
- Female
- Hematocrit
- Humans
- Hyperparathyroidism
(blood, diagnosis, epidemiology)
- Immunosuppressive Agents
(adverse effects)
- Incidence
- India
(epidemiology)
- Kidney Transplantation
(adverse effects)
- Living Donors
- Male
- Middle Aged
- Polycythemia
(blood, diagnosis, epidemiology)
- Prospective Studies
- Retrospective Studies
- Time Factors
- Transplant Recipients
- Treatment Outcome
- Young Adult
|